New antiepileptic drugs in children: Present and future

The pharmacologic management of epilepsy has progressed greatly during the last decade. New medications are available for the management of refractory patients, and more are being developed. For some patients, these productions offer added efficacy, better tolerability, and some pharmacodynamic adva...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in pediatric neurology 1997-03, Vol.4 (1), p.9-18
Main Authors: Pellock, John M., Watemberg, Nathan
Format: Article
Language:English
Subjects:
Anticonvulsants - therapeutic use
Child
Epilepsy - drug therapy
Humans
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pharmacologic management of epilepsy has progressed greatly during the last decade. New medications are available for the management of refractory patients, and more are being developed. For some patients, these productions offer added efficacy, better tolerability, and some pharmacodynamic advantages. Since preapproval studies include few pediatric trials, the final role of these medications in the treatment of childhood epilepsy will be dictated by additional studies and postmarketing experience.
ISSN:1071-9091
1558-0776
DOI:10.1016/S1071-9091(97)80004-6